ivabradine has been researched along with natriuretic peptide, c-type in 1 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (natriuretic peptide, c-type) | Trials (natriuretic peptide, c-type) | Recent Studies (post-2010) (natriuretic peptide, c-type) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 1,413 | 31 | 477 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kavtaradze, N; Saganelidze, K | 1 |
1 review(s) available for ivabradine and natriuretic peptide, c-type
| Article | Year |
|---|---|
[MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF HEART FAILURE, AS A MANIFESTATION OF ANTHRACYCLINE CARDIOTOXICITY (REVIEW)].
Topics: Anthracyclines; Antineoplastic Agents; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Echocardiography; Elapid Venoms; Heart; Heart Failure; Humans; Ivabradine; Natriuretic Peptide, C-Type; Neoplasms; Survival Analysis; Trastuzumab; Trimetazidine; Troponin I | 2018 |